Clinical Trials · NCT04016974
A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 32
- Start date
- Oct 2019
- Locations
- 1 site, China
- Primary endpoint
- AUC0-24h,sema,SS, area under the semaglutide concentration-time curve during a dosing interval (0-24 hours) at steady state